Searched for
180 DAY EXCLUSIVITY
Maternity cover in group health insurance plans: Why outdated limits leave employees paying more out of pocketOne of the biggest advantages of a group policy is the waiver of the maternity waiting period. In individual policies, maternity typically ...- Virat Kohli safe, Rohit Sharma faces 2027 ODI World Cup challenge, says Saba KarimVirat Kohli's place in the 2027 ODI World Cup squad is assured. His fitness and consistent scoring have convinced selectors. Rohit Sharma f...
- New Dubai shared housing rental law: 5 big changes as land department can now order tenant eviction, cancel landlord permits if new rules are not followedDubai is introducing a new law for shared housing. Landlords must get permits from the Dubai Land Department. Non-compliance can lead to te...
- Less than 24 hours in Hospital? Know about health insurance coverage for day care treatments, surgeries, and emergency proceduresMany policyholders believe health insurance claims require a 24-hour hospital stay. However, modern policies cover numerous treatments comp...
- Best ways to find the right health insurance policy: A comparison of ICICI Lombard, HDFC Ergo, Care, Niva Bupa, Tata AIG policiesChoosing a health insurance policy involves more than just premium cost. This comparison of leading Indian insurers highlights key features...
- UPI underdogs seek fair play; WhatsApp tightens scam defencesSmaller UPI players will meet NPCI to curb the growth of industry leaders PhonePe, Google Pay and Paytm. This and more in today’s ETtech To...
- Snabbit raises $56 million from Susquehanna VC, Mirae, others; valuation doubles to $350 millionSnabbit, an instant house help startup, has secured $56 million in a new funding round. This investment, led by Susquehanna Venture Capital...
- Granules India gets USFDA tentative nod for generic ADHD treatment tabletsGranules Pharmaceuticals, Inc., a subsidiary of Granules India, has achieved a significant milestone with the tentative green light from US...
- Lupin launches generic injection in US with 180-day exclusivityIn an exciting development for mental health treatment, Lupin has introduced a generic version of a medication for schizophrenia and bipola...
- Natco Pharma launches generic drug with 180-day exclusivity in USNatco Pharma has launched Bosentan tablets, a generic version of Tracleer, in the US for treating pulmonary arterial hypertension in young ...
- Glenmark gets USFDA nod for generic drug with 180-day exclusivityThe USFDA noted that the Mumbai-based drug firm was the first abbreviated new drug application (ANDA) applicant with a paragraph IV certifi...
- Zydus Cadila gets USFDA nod for arthritis drug with 180-days exclusivityZydus was the first abbreviated new drug application (ANDA) filer on Tofacitinib extended-release tablets 22 mg and thus holds 180-day excl...
- Ranbaxy loses approvals, exclusivity of two drugs in USIn November, Ranbaxy had sued USFDA over revoking an approval to sell generic versions of Nexium and Valcyte in the US.
- Ranbaxy forfeits 180 days exclusivity for generic NexiumRanbaxy said USFDA has determined that it has forfeited its 180-day exclusivity to sell generic version of digestive disorder medicine Nexi...
- Sanofi files cases against Glenmark on patent infringementSanofi had submitted its application to seek US Food and Drug Administration's (USFDA's) approval for its generic version of the drug on Ja...
- Wockhardt launches generic Parkinson's treatment drug in USDrug maker Wockhardt today said it has launched a generic version of Orion Corporation's Parkinson's treatment drug Stalevo in the US.
- Glenmark gets first-to-file status for 3 drugs in USGlenmark Pharmaceuticals has received first-to-file status for three of its abbreviated new drug applications (ANDA) that have a combined r...
- Ranbaxy gets USFDA approval for migraine drugIndia's largest drugmaker, Ranbaxy Laboratories, has received marketing approval to sell the low-cost version of GlaxoSmithKine's anti-migr...
- Glenmark confirms Abbott suit against Tarka genericGlenmark Pharmaceuticals has confirmed that Abbott has filed a suit in the US District Court of New Jersey on December 7, seeking to preven...
- Ranbaxy wins 180-day exclusivity for simvastatinThe US Court of Appeals has upheld the 180-day exclusivity of Ranbaxy’s cholesterol-lowering drug simvastatin, reports Our Bureau. It has a...
Load More
